IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 4 filers reported holding IMPAX LABORATORIES INC in Q2 2012. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $223,000 | 0.0% | 4,764 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $223,000 | +3.7% | 4,764 | -29.7% | 0.01% | 0.0% |
| Q4 2014 | $215,000 | +10650.0% | 6,781 | +7037.9% | 0.01% | – |
| Q2 2012 | $2,000 | -92.3% | 95 | -90.9% | 0.00% | -100.0% |
| Q1 2012 | $26,000 | +73.3% | 1,039 | +35.6% | 0.00% | 0.0% |
| Q4 2011 | $15,000 | +7.1% | 766 | 0.0% | 0.00% | 0.0% |
| Q3 2011 | $14,000 | -17.6% | 766 | 0.0% | 0.00% | 0.0% |
| Q2 2011 | $17,000 | -69.1% | 766 | -64.5% | 0.00% | -50.0% |
| Q1 2011 | $55,000 | – | 2,159 | +9713.6% | 0.00% | – |
| Q2 2010 | $0 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,415,600 | $162,414,000 | 1.91% |
| Broadfin Capital, LLC | 1,217,858 | $36,524,000 | 1.80% |
| NEW AMSTERDAM PARTNERS LLC/NY | 695,100 | $20,846,000 | 1.36% |
| Healthcare Value Capital, LLC | 50,000 | $1,500,000 | 1.26% |
| Iguana Healthcare Management, LLC | 75,000 | $2,249,000 | 1.05% |
| Matarin Capital Management, LLC | 78,292 | $2,347,977,000 | 1.04% |
| Independence Capital Asset Partners, LLC | 253,089 | $7,590,000 | 1.04% |
| Tekla Capital Management LLC | 344,683 | $10,337,000 | 0.95% |
| Penn Capital Management Company, LLC | 794,641 | $23,831,000 | 0.92% |
| Leonard Capital Management, Inc. | 87,661 | $2,629,000 | 0.89% |